Publications

5808 Results

Pathologic and phenotypic features of gastric cancer.

Authors
CM Fenoglio-Preiser;AE Noffsinger;J Belli;GN Stemmermann
Journal / Conference
Seminars in Oncology 23(3):292-306
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Is interferon-y detrimental? Results of a Southwest Oncology Group randomized trial of adjuvant human interferon-y versus observation in malignant melanoma.

Authors
VK Sondak;KJ Kopecky;JW Smith II;CW Taylor;RD Noyes;RJ Tuthill;EM Hersh;LG Feun;JD Doroshow;LE Flaherty;FL Meyskens Jr
Journal / Conference
Proc of the 8th Intl Conference on the Adjuvant Therapy of Cancer :51(#31)
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8642

Induction cisplatin/vinblastine decreased distant metastasis in unresectable squamous cell lung cancer (SCC): Failure patterns.

Authors
R Komaki;CB Scott;WT Sause;S Taylor IV;DH Johnson;R Livingston;B Emami;WJ Curran;RW Byhardt;AR Dar;AT Turrisi;JD Cox
Journal / Conference
International Journal of Radiation Oncology Biology Physics 36(1):206(#96)
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Superiority of a brief course of CHOP plus radiotherapy (RT) over CHOP alone in localized unfavorable non-Hodgkin's lymphoma (NHL) is seen in lowest risk subgroups: A Southwest Oncology Group study.

Authors
TP Miller;S Dahlberg;JR Cassady;C Spier;TM Grogan;S Carlin;E Chase;RI Fisher
Journal / Conference
Annals of Oncology 7(3):23(#076)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

Surgical therapy of primary cutaneous melanoma.

Authors
PJ Geraghty;TM Johnson;VK Sondak;AE Chang
Journal / Conference
Seminars in Surgical Oncology 12:386-393
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group study.

Authors
SE Rivkin;S Green;B Metch;H Glucksberg;N Gad-el-Mawla;JJ Constanzi;B Hoogstraten;J Athens;T Maloney;CK Osborne;CB Vaughn
Journal / Conference
Classic Papers and Current Comments 1(1):85-93
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;B Metch;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;JP Minton;CK Osborne
Journal / Conference
Classic Papers and Current Comments 1(1):120-128
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;B Metch;WR Jewell;JJ Costanzi;SJ Altman;JP Minton;RM O'Bryan;CK Osborne
Journal / Conference
Classic Papers and Current Comments 1(1):129-135
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial.

Authors
CP Karakousis;CM Balch;MM Urist;MM Ross;TJ Smith;AA Bartolucci
Journal / Conference
Annals of Surgical Oncology 3(5):446-452
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)

A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG Inter-group study.

Authors
KR Rai;B Peterson;L Elias;L Shepherd;J Hines;D Nelson;B Cheson;J Kolitz;CA Schiffer
Journal / Conference
Blood 88:141a(#552)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)